Objective: To investigate the correlation between thyroid function stratification and autoantibody titers in patients with Graves’ disease (GD) under different iodine nutrition conditions. Methods: The levels of serum thyroid hormones, autoantibodies and urinary iodine in 100 patients with different thyroid function GD [GD-A, GD-B] and 60 healthy subjects are detected by electrochemical immunoluminescence and iodine-catalyzed arsenic-cerium method. Results: The proportion of GD patients with the sum of iodine overdosage and iodine overdosage group is consistent with iodine adequate group, which is significantly higher than iodine deficiency group, and the (Median Urine Iodine, MUI) of GD-A group is significantly higher than GD-B group. Urinary iodine levels in GD group and GD-A group are positively correlated with serum FT3 and FT4 (P<0.05), and negatively correlated with (thyroid stimulating hormone, TSH) (P<0.05). The levels of serum (thyroid peroxidase antibody, TPOAb) and (thyroid globulin antibody, TGAb) in each GD group are significantly higher than those in the control group. Serum TSH levels in the high TPOAb group and high TgAb group are lower than those in the low TPOAb group, low TgAb group and control group, respectively. The levels of FT3 and FT4 are higher than those of the low TPOAb group and the low TgAb group, however, there is no significant difference between the FT3 of low TgAb and T3 and T4 levels that belong to the control group, high TPOAb group, high TgAb group, low TPOAb group, and low TgAb group. In conclusion: GD patients with different thyroid functions have corresponding changes in their thyroid hormone and autoantibody levels under different iodine nutrition conditions, which indicates that iodine nutrition status involve in and play an important role in the development of GD with different thyroid functions and different antibody levels.
Published in | Science Journal of Public Health (Volume 8, Issue 6) |
DOI | 10.11648/j.sjph.20200806.13 |
Page(s) | 168-176 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2020. Published by Science Publishing Group |
Thyroid Hormone, Median Urine Iodine, Thyroid Autoantibodies, Graves’ Disease, Hyperthyroidism
[1] | Wang L, Wang B, Chen SR, et al. Effect of Selenium Supplementation on Recurrent Hyperthyroidism Caused by Graves' Disease: A Prospective Pilot Study [J]. HormMetab Res, 2016, 48 (9): 559-564. |
[2] | Burch HB, Cooper DS. Management of Graves’disease: A Review [J]. JAMA, 2015, 314 (23): 2544-2554. |
[3] | Li HX, Xiang N, Hu WK, et al. Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis [J]. J Endocrinol Invest, 2016, 39 (11): 1225-1233. |
[4] | Su JP, Su SO, Zhang B, et al. The effects of different iodine intake on autoimmune of Graves'disease [J]. Clin Med China, 2012, 28 (1): 44-46. |
[5] | San ZY. Guide to diagnosis and Treatment of Thyroid diseases in China [J]. Chin J Prac Inter Med, 2008, 28 (4): 260-261. |
[6] | Chinese Medical Association Endocrine Credits “China thyroid disease treatment guidelines” Writing Group. China thyroid disease treatment guidelines-iodine deficiencydisorders [J]. Journal of Internal Medicine, 2008, 47 (8): 689-690. |
[7] | Zhang YP, Yan YQ, Liu L J, et al. Urine ammonium persulfate digestion with a low arsenic content arsenic cerium catalytic spectrophotometric method [J]. Chin J Endemiol, 2013, 32 (1): 95-100. |
[8] | Wu ZF, LiangY, Chen XQ. Investigation of urinary iodine in patients with thyroid disease [J]. You Jiang Med, 2010, 38 (2): 188-189. |
[9] | Huang SY, Yan YM, Wu M, et al. Analysis of Urinary Iodine Content of Newly Diagnosed Thyroid Disease Patients in Xiaogan [J]. Guangzhou Microelement Science 2015, 22 (1): 24-27. |
[10] | Wang FL, Hou ZJ, Liu YZ, et al. Analysis of iodine nutritional status in patients with abnormal thyroid function [J]. China Medi Herald, 2018, 15 (25): 64-67. |
[11] | Laurberg P, Cerqueira C, Ovesen L, et al. Iodine intake as a determinant of thyroid disorders in populations [J]. Best Pract Res Clin Endocrinol Metab, 2010, 24 (1): 13-27. |
[12] | Tan X, Cao XX, He L. Effect of iodine excess on thyroid function and its pathogenesis of diseases [J]. Chin J Ctrl Endem Dis, 2019, 34 (1): 35-37. |
[13] | Li K, Yu FC, Kang WM. Iodine intake and thyroid disease [J]. Chin J Endem, 2016, 35 (3): 166-169. |
[14] | Zhang KZ, Lin YC, Fang ZP, et al. The effect of salt iodization for 10 years on the prevalences of endemic goiter and hyperthyroidism [J]. Chin J EndocrinolMetab, 2002, 18 (5): 342-344. |
[15] | Hou X, Wang J, QQ, et al. Epidemiologic comparative study of hyperthyroidism beforeand after salt iodization in different iodine intake regions of Jilin province [J]. Chin J Endocrinol Meta, 2003, 19 (2): 104-105. |
[16] | Fan X, Chen SK. Relationship of Io dine Excessiveness an d T hyroid Function [J]. Med Reca, 2011, 17 (14): 2165-2167. |
[17] | Mostbeck A, Galvan G, Bauer P, et al. The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. Eur J Nucl Med, 1998, 25: 367-374. |
[18] | Li CQ, Yin HQ, Zhang CK, et al. Epidemiological investigation of Graves's disease in one hundred thousand people in Daqingarea [J]. National Medical Journal of China, 1996, 76 (6): 443-446. |
[19] | Shan Z, Chen L, Lian X, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a crosssectional study in 10 cities [J]. Thyroid 2016, 26 (8): 1125-1130. |
[20] | JinY, Teng WP, Yuan B, et al. Thyroid autoimmunity in members from multiplex families with Graves' disease and effect of iodine intake on its incidence [J] Chin J Endocrinol Metab, 2001, 17 (2): 79-82. |
[21] | Yan SL, Wang YG, Wang F, et al. Relationship between iodine in urine and Graves's disease along coastal district in shading [J]. Chin J Endem, 2004, 23 (3): 245-247. |
[22] | Na BQ, Zhang XL, Wang SY, et al. Analysis of thyroid function under different iodine nutritional status [J]. Chin J Endem, 2019, 38 (3): 235-238. |
[23] | Chen XM, Guo ZQ, Zhou F, et al. Correlation of concentrations of iodine in urine with Graves disease along coastal area of western Guangdong [J]. China Tropi Med, 2010, 10 (8): 922-923. |
[24] | Cong JN, Zhao YJ, Li G, et al. The changes of SOD and MDA in serum of patients with autoimmune thyroid disease and the relationship between SOD and urine iodine Guangzhou Microelement Science, 2011, 18 (8): 12-15. |
[25] | Teng W, Shan Z, Teng X, et al, Effect of iodine intake on thyroid disea-ses in China [J]. N Engl J Med, 2006, 354 (26): 2783-2793. |
[26] | Huang WT, Huang W, Chang ZY, et al. Sundy on the relations between Graves disease (GD) and urine iodine in Guishinan area [J]. Chin J Ctrl Endem, 2004, 19 (2): 117-119. |
[27] | Yang F, Shan ZY, Teng XC, et al. Chronic iodine excess does not increase the incidence of hyperthyroidism: a prospective community-based epidemiological survey in China [J]. Eur J Endocrinol. 2007, 156 (4): 403-408. |
[28] | Hu FN, Teng XC, Teng WP, et al. A comparative epidemic study of goiter and thyroid nodules in areas with different iodine intake [J]. Chin J Endem, 2002, 21 (6): 464-467. |
[29] | Teng WP. Common salt iodization and hyperthyroidism [J]. Chin J Endocrinol Metab 2000, 16 (3): 137-138. |
[30] | Wang YJ, ZhouW, Yang CX. Relationship between iodine nutritional status and thyroid disease in the elderly [J]. Cardiovascular Dise J integtradil Chin West Med, 2018, B6 (5): 98-99. |
[31] | Ren YT, Jia QZ, Zhang XD, et al. Epidemiological in vestigation on thyroid disease a mongfertile women in diferent iodine in take areas of Shanxi province [J]. Chin J Epidemiol, 2014, 35 (1): 45-48. |
[32] | Wang XL, OsimanReziwan, Ma FH, et al. Changes of thyroid function, thyroid antibodies and urinary iodine among permanent residents of Urumqi in Xinjiang [J]. Chin J Epidemiol, 2015, 36 (8): 811-814. |
[33] | Xu YH, Cheng DX, Jin YS, et al. The significance of iodine intake and TRAb in the pathogenesis and clinical outcome of Graves disease [J]. Chia Mod Med, 2016, 23 (28): 75-77. |
[34] | Li YS, Jin Y, Teng WP, et al. The Comparative Screening for Thyroid Autoantibodies in Areas with Different Iodine Intakes [J]. Shanghai J Immun 2002, 22 (2): 91-95. |
[35] | Burek CL, Hoffman WH, Rose NR. The presence of thyroid autoantibodies in children and adolescents with autoimmune thyroid disease and in their siblings and parents [J]. ClinImmunol Immunopathol, 1982, 25 (3): 395-404. |
[36] | Song XX, Guo YY, Ma XQ. Analysis of thyroid function and the iodine nutrition status of Uygur and Han hospitalized patients in Xinjiang [J]. Hainan Med J, 2016, 27 (24): 3994-3997. |
[37] | Chen XY, Zhang ZT, Deng SY, et al. Clinical manifestation of Graves disease patients with different levels of thyroid related autoantibodies [J]. New Med, 2011, 42 (12): 789-792. |
[38] | Wang B, Meng JH. Research of thyroid autoantibodies in the diagnosis of Graves’s disease and Hashimoto’s thyroiditis s [J]. Chin J Lab Diagn. 2018, 22 (2): 207-209. |
[39] | Wang YL, Yao PW, Zhou LL, et al. Recurrence of Hyperthyroidism in Patients with Graves’sdisease and Elevated Thyrotropin Receptor Antibody Levels [J]. Acta Med UnivSci Tech Hua zhong, 2016, 45 (1): 95-97 |
[40] | Qin C, Zhang Q. Influence of Iodine Nutrient Status on Autoimmune Thyroid Disease in Iodine Super Excessive Area [J]. J Guiyang Med Coll, 2016, 41 (2): 194-196. |
[41] | Yang F, Teng WP, Shan ZY, et al. A comparative epidemiologic survey of hyperthyroidism in areas with different iodine intake [J]. Chin J Endocrinol Metab, 2001, 17 (4): 197-201. |
APA Style
Jing Feng, Cuicui Wang, Zhaoxin Mu, Xinsheng Li, Zhenjiang Hou. (2020). Correlation Analysis of Thyroid Function and Autoantibodies in Graves’ Disease Patients with Different Iodine Nutritional Status. Science Journal of Public Health, 8(6), 168-176. https://doi.org/10.11648/j.sjph.20200806.13
ACS Style
Jing Feng; Cuicui Wang; Zhaoxin Mu; Xinsheng Li; Zhenjiang Hou. Correlation Analysis of Thyroid Function and Autoantibodies in Graves’ Disease Patients with Different Iodine Nutritional Status. Sci. J. Public Health 2020, 8(6), 168-176. doi: 10.11648/j.sjph.20200806.13
AMA Style
Jing Feng, Cuicui Wang, Zhaoxin Mu, Xinsheng Li, Zhenjiang Hou. Correlation Analysis of Thyroid Function and Autoantibodies in Graves’ Disease Patients with Different Iodine Nutritional Status. Sci J Public Health. 2020;8(6):168-176. doi: 10.11648/j.sjph.20200806.13
@article{10.11648/j.sjph.20200806.13, author = {Jing Feng and Cuicui Wang and Zhaoxin Mu and Xinsheng Li and Zhenjiang Hou}, title = {Correlation Analysis of Thyroid Function and Autoantibodies in Graves’ Disease Patients with Different Iodine Nutritional Status}, journal = {Science Journal of Public Health}, volume = {8}, number = {6}, pages = {168-176}, doi = {10.11648/j.sjph.20200806.13}, url = {https://doi.org/10.11648/j.sjph.20200806.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20200806.13}, abstract = {Objective: To investigate the correlation between thyroid function stratification and autoantibody titers in patients with Graves’ disease (GD) under different iodine nutrition conditions. Methods: The levels of serum thyroid hormones, autoantibodies and urinary iodine in 100 patients with different thyroid function GD [GD-A, GD-B] and 60 healthy subjects are detected by electrochemical immunoluminescence and iodine-catalyzed arsenic-cerium method. Results: The proportion of GD patients with the sum of iodine overdosage and iodine overdosage group is consistent with iodine adequate group, which is significantly higher than iodine deficiency group, and the (Median Urine Iodine, MUI) of GD-A group is significantly higher than GD-B group. Urinary iodine levels in GD group and GD-A group are positively correlated with serum FT3 and FT4 (P<0.05), and negatively correlated with (thyroid stimulating hormone, TSH) (P<0.05). The levels of serum (thyroid peroxidase antibody, TPOAb) and (thyroid globulin antibody, TGAb) in each GD group are significantly higher than those in the control group. Serum TSH levels in the high TPOAb group and high TgAb group are lower than those in the low TPOAb group, low TgAb group and control group, respectively. The levels of FT3 and FT4 are higher than those of the low TPOAb group and the low TgAb group, however, there is no significant difference between the FT3 of low TgAb and T3 and T4 levels that belong to the control group, high TPOAb group, high TgAb group, low TPOAb group, and low TgAb group. In conclusion: GD patients with different thyroid functions have corresponding changes in their thyroid hormone and autoantibody levels under different iodine nutrition conditions, which indicates that iodine nutrition status involve in and play an important role in the development of GD with different thyroid functions and different antibody levels.}, year = {2020} }
TY - JOUR T1 - Correlation Analysis of Thyroid Function and Autoantibodies in Graves’ Disease Patients with Different Iodine Nutritional Status AU - Jing Feng AU - Cuicui Wang AU - Zhaoxin Mu AU - Xinsheng Li AU - Zhenjiang Hou Y1 - 2020/11/27 PY - 2020 N1 - https://doi.org/10.11648/j.sjph.20200806.13 DO - 10.11648/j.sjph.20200806.13 T2 - Science Journal of Public Health JF - Science Journal of Public Health JO - Science Journal of Public Health SP - 168 EP - 176 PB - Science Publishing Group SN - 2328-7950 UR - https://doi.org/10.11648/j.sjph.20200806.13 AB - Objective: To investigate the correlation between thyroid function stratification and autoantibody titers in patients with Graves’ disease (GD) under different iodine nutrition conditions. Methods: The levels of serum thyroid hormones, autoantibodies and urinary iodine in 100 patients with different thyroid function GD [GD-A, GD-B] and 60 healthy subjects are detected by electrochemical immunoluminescence and iodine-catalyzed arsenic-cerium method. Results: The proportion of GD patients with the sum of iodine overdosage and iodine overdosage group is consistent with iodine adequate group, which is significantly higher than iodine deficiency group, and the (Median Urine Iodine, MUI) of GD-A group is significantly higher than GD-B group. Urinary iodine levels in GD group and GD-A group are positively correlated with serum FT3 and FT4 (P<0.05), and negatively correlated with (thyroid stimulating hormone, TSH) (P<0.05). The levels of serum (thyroid peroxidase antibody, TPOAb) and (thyroid globulin antibody, TGAb) in each GD group are significantly higher than those in the control group. Serum TSH levels in the high TPOAb group and high TgAb group are lower than those in the low TPOAb group, low TgAb group and control group, respectively. The levels of FT3 and FT4 are higher than those of the low TPOAb group and the low TgAb group, however, there is no significant difference between the FT3 of low TgAb and T3 and T4 levels that belong to the control group, high TPOAb group, high TgAb group, low TPOAb group, and low TgAb group. In conclusion: GD patients with different thyroid functions have corresponding changes in their thyroid hormone and autoantibody levels under different iodine nutrition conditions, which indicates that iodine nutrition status involve in and play an important role in the development of GD with different thyroid functions and different antibody levels. VL - 8 IS - 6 ER -